Search PDMR transactions

Notifier
Name of person with notification obligation
Axel Schörling
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Axel Schörling
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
No
Amendment
Yes
Details of amendment
Ändrat instrument från teckningsoption till aktie
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
EQL Pharma AB
Issuer´s LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share EQL Pharma AB SE0005497732 Exercise increase 400,000 Quantity 67.50 SEK 05/09/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EQL Pharma AB SE0005497732 Exercise increase 05/09/2025 Outside a trading venue 400,000 (Quantity) 67.50 SEK
Total: 400,000
<< Back